- Home
- IMMX vs GRDI Comparison
IMMX vs GRDI Comparison
Compare IMMX & GRDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMX
- GRDI
- Stock Information
- Founded
- IMMX 2014
- GRDI 2018
- Country
- IMMX United States
- GRDI United States
- Employees
- IMMX N/A
- GRDI N/A
- Industry
- IMMX Medicinal Chemicals and Botanical Products
- GRDI
- Sector
- IMMX Health Care
- GRDI
- Exchange
- IMMX Nasdaq
- GRDI NYSE
- Market Cap
- IMMX 51.1M
- GRDI 53.9M
- IPO Year
- IMMX 2021
- GRDI N/A
- Fundamental
- Price
- IMMX $1.41
- GRDI $0.77
- Analyst Decision
- IMMX Strong Buy
- GRDI
- Analyst Count
- IMMX 1
- GRDI 0
- Target Price
- IMMX $7.00
- GRDI N/A
- AVG Volume (30 Days)
- IMMX 144.1K
- GRDI 36.6K
- Earning Date
- IMMX 11-11-2024
- GRDI 01-01-0001
- Dividend Yield
- IMMX N/A
- GRDI N/A
- EPS Growth
- IMMX N/A
- GRDI N/A
- EPS
- IMMX N/A
- GRDI 0.35
- Revenue
- IMMX N/A
- GRDI $20,943,000.00
- Revenue This Year
- IMMX N/A
- GRDI N/A
- Revenue Next Year
- IMMX $200.00
- GRDI N/A
- P/E Ratio
- IMMX N/A
- GRDI $2.67
- Revenue Growth
- IMMX N/A
- GRDI 8.57
- 52 Week Low
- IMMX $1.26
- GRDI $0.56
- 52 Week High
- IMMX $7.75
- GRDI $9.66
- Technical
- Relative Strength Index (RSI)
- IMMX 41.10
- GRDI 40.46
- Support Level
- IMMX $1.44
- GRDI $0.70
- Resistance Level
- IMMX $1.80
- GRDI $0.81
- Average True Range (ATR)
- IMMX 0.16
- GRDI 0.07
- MACD
- IMMX 0.01
- GRDI 0.00
- Stochastic Oscillator
- IMMX 46.10
- GRDI 30.00
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
About GRDI GRIID INFRASTRUCTURE INC
Griid Holdco LLC is a vertically integrated Bitcoin mining company. It owns and operates a growing portfolio of energy infrastructure and high-density data centers across North America. The Company has built a cryptocurrency mining operation, which operates specialized computers (also known as miners) that generate cryptocurrency. Currently, the only cryptocurrency mined by GRIID is Bitcoin.